Gregory Vladimer

Co-founder and CEO at Graph Therapeutics FlexCo

Speaker

Gregory Vladimer is co-founder and managing director of Vienna-based Graph Therapeutics, a techbio startup driving drug discovery and development in the inflammation and immunology (I&I) space.

Gregory is a distinguished entrepreneur and immunologist, recognized for his work in AI-driven drug discovery platforms. As a co-founder of Allcyte, he co-led the company's $60M exit and subsequent $510M IPO of Exscientia.

With a PhD in immunology, Gregory has made significant contributions to the field. His expertise spans both scientific research and business leadership, having raised over $20M in fundraising and research funding throughout his career. His innovative approach to healthcare has earned him multiple accolades, including being named 2023 Endpoint News LGBTQ+ Biotech Leader. He has also received consecutive Prix Galien awards in 2022, 2023, and 2024.